Professor Saša Pekeč will discuss how transformative digital and data technologies are profoundly affecting businesses and how they propelled the platform business model to its current prominence. He will also present related emerging challenges brought up by reliance on data-driven decision-making. Join the discussion via LinkedIn Live.
What you'll learn:
-Key principles of Adaptive Biotechnologies' quantitative immunoSEQ Technology and applications in immune-oncology, transplantation and COVID-19 research
-Introduction to the immunoSEQ kit and how it has been used in research
-immunoSEQ T-MAP COVID and its utility in propelling COVID-19 research forward
We are lucky to have Dr. Anthony G. Visco, MD, Professor and Chief of the Urogynecology Division and Chair of the DUH Robotic Committee, speak with us about his process of founding NinoMed. Dr. Visco is the President and CEO of NinoMed, which is a medical device and business analytics company that provides a wide variety of healthcare products including:
We welcome Duke Trustee and co-founder of Partners In Health, Dr. Paul Farmer '82, P'19, who has been recognized internationally for his impactful work at the intersection of public health and human rights.
For this exclusive discussion, Dr. Farmer will be joined by top faculty from the Duke Global Health Institute (DGHI), who are re-imagining solutions to the most pressing medical challenges in Latin America and the Caribbean.
Join Jimmie Lenz, Director of the Master of Engineering in Cybersecurity program, for an interview with Mark Carney from Coalfire.
Pratt Research Fellows conduct intensive research while studying as undergraduate engineering students at Duke. Register to attend the virtual 2021 Pratt Fellows Poster Session: https://duke.qualtrics.com/jfe/form/SV_6fHSQlWhiqptmOG
On April 5, 2021 the US Supreme Court in a 6-2 decision in the copyright case of Google v Oracle found that Google's use of the APIs from 37 Java packages in the Android platform was legally a "fair use", thus deciding the case in favor of Google. This decision was the culmination of more than ten years of litigation and two jury trials whose decisions were each overturned on appeal, before being ultimately determined by the Supreme Court.
The growth in martech, or technologies to scale and automate marketing, has been explosive. Today, there are over 8,000 major martech companies compared to just 900 in 2014. Professor Carl Mela will discuss key reasons that underpin growth in martech and summarize its major components including ad tech, content marketing, and B2B, B2C, and C2C platforms including sales tech, social media, the peer economy, and reputation platforms. He will also outline a more strategic approach to creating and managing your martech stack. Join the discussion via LinkedIn Live.
The early designers of the Internet fostered tremendous innovation by leaving much of the network's functionality to the programmable computers at its periphery. Unfortunately, the *inside* of the network has been much harder to change. Yet, changing the network is important to make the Internet more reliable, secure, performant, and cost-effective. The networking research community has struggled for many years to make networks more programmable. What has worked, and what hasn't, and what lessons have we learned along the way?
Dr. Jeffrey Fredberg's laboratory investigates physical processes expressed by the eukaryotic cell, such as its deformability, contractility, malleability, and motility. His team turned attention more recently from the single cell in isolation to the cellular collective as it might pertain, for example, to disruption of the bronchial epithelial layer in asthma or tumor invasion in breast cancer.